Tirzepatide is a synthetic dual receptor agonist targeting the GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptors. It is used in preclinical and experimental studies on glucose metabolism, insulin regulation and metabolic research.
For research purposes only. This product is intended exclusively for laboratory and scientific research applications. Not suitable for use in humans or animals. Not intended for the diagnosis, treatment, cure, or prevention of any disease.
